UA100902U - Method for treating microglandular hyperplasia of uterine cervix in patients with impaired vegetative homeostasis - Google Patents

Method for treating microglandular hyperplasia of uterine cervix in patients with impaired vegetative homeostasis

Info

Publication number
UA100902U
UA100902U UAU201502465U UAU201502465U UA100902U UA 100902 U UA100902 U UA 100902U UA U201502465 U UAU201502465 U UA U201502465U UA U201502465 U UAU201502465 U UA U201502465U UA 100902 U UA100902 U UA 100902U
Authority
UA
Ukraine
Prior art keywords
impaired
patients
treating
uterine cervix
microglandular
Prior art date
Application number
UAU201502465U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Володимир Васильович Подольський
Original Assignee
Державна Установа "Інститут Педіатрії, Акушерства І Гінекології Намн України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державна Установа "Інститут Педіатрії, Акушерства І Гінекології Намн України" filed Critical Державна Установа "Інститут Педіатрії, Акушерства І Гінекології Намн України"
Priority to UAU201502465U priority Critical patent/UA100902U/en
Publication of UA100902U publication Critical patent/UA100902U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The method for treating microglandular hyperplasia of the uterine cervix in the patients with impaired vegetative homeostasis comprises the use of hyaluronic acid. Cicatridina and Actovegin are provided at the mean therapeutic doses. Antifront is used at a dose of 10-15 drops.
UAU201502465U 2015-03-19 2015-03-19 Method for treating microglandular hyperplasia of uterine cervix in patients with impaired vegetative homeostasis UA100902U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201502465U UA100902U (en) 2015-03-19 2015-03-19 Method for treating microglandular hyperplasia of uterine cervix in patients with impaired vegetative homeostasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201502465U UA100902U (en) 2015-03-19 2015-03-19 Method for treating microglandular hyperplasia of uterine cervix in patients with impaired vegetative homeostasis

Publications (1)

Publication Number Publication Date
UA100902U true UA100902U (en) 2015-08-10

Family

ID=54771989

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201502465U UA100902U (en) 2015-03-19 2015-03-19 Method for treating microglandular hyperplasia of uterine cervix in patients with impaired vegetative homeostasis

Country Status (1)

Country Link
UA (1) UA100902U (en)

Similar Documents

Publication Publication Date Title
PH12018502251A1 (en) Formulations of an lsd1 inhibitor
PH12017502142A1 (en) Tetrasubstituted aklene compounds and their use
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
MX2017014338A (en) Targeted selection of patients for treatment with cortistatin derivatives.
MX2016007709A (en) A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy.
IN2015DN00450A (en)
MX2021002321A (en) Novel methods.
MX370953B (en) USE OF LEVOCETIRIZINE and MONTELUKAST IN THE TREATMENT OF AUTOIMMUNE DISORDERS.
MX2019003134A (en) Combination therapy.
AU201812597S (en) Patient interface mask for CPAP therapy
MX2020001727A (en) Combination therapy.
MX2015011671A (en) Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis.
PH12017500392A1 (en) Medical treatments based on anamorelin
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2019005309A (en) Anti-bag3 antibodies in combination with inhibitors of immune check-point for therapeutic use.
MY186840A (en) Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy
MA39599A (en) Dosage and administration anti-egfr therapeutics
MX2016011706A (en) Progesterone formulations.
UA100902U (en) Method for treating microglandular hyperplasia of uterine cervix in patients with impaired vegetative homeostasis
AR102494A1 (en) METHODS TO TREAT EYE DISEASES
UA95686U (en) MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM
UA92452U (en) Method for healing topical radiation lesions of skin
TWD183905S (en) Medical apparatus
UA95687U (en) MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM
UA104733U (en) A method of treating gastropathy in patients with chronic obstructive pulmonary disease